×
About 215 results

ALLMedicine™ Hepatitis Testing Center

Research & Reviews  65 results

Development of performance indicators for hepatitis countermeasures as a tool for the a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841952
Journal of Gastroenterology; Shimakami T, Setoyama H et. al.

Jan 17th, 2023 - Hepatitis countermeasures are being promoted by governments in Japan. We aimed to develop performance indicators (PIs) to assess the process and outcome of such countermeasures implemented for the prevention of viral hepatitis-related liver cancer...

A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients
https://clinicaltrials.gov/ct2/show/NCT03284242

Jan 17th, 2023 - The purpose of this research study is to learn alternative ways to control the body's immune responses after renal transplantation. The investigator's goal is to prevent or reduce the side-effects of long-term immunosuppressive therapy. By doing t...

Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identif...
https://doi.org/10.1111/liv.15414
Liver International : Official Journal of the Internation... Jacob R, Prince DS et. al.

Sep 3rd, 2022 - Significant barriers exist with hepatitis B (HBV) case detection and effective linkage to care (LTC). The emergency department (ED) is a unique healthcare interaction where hepatitis screening and LTC could be achieved. We examined the efficacy an...

Blood-borne virus testing in emergency departments - a systematic review of seroprevale...
https://doi.org/10.1111/hiv.13328
HIV Medicine; Simmons R, Plunkett J et. al.

Jun 16th, 2022 - Blood-borne viruses (BBVs) cause significant morbidity and mortality worldwide. Emergency departments (EDs) offer a point of contact for groups at increased risk of BBVs who may be less likely to engage with primary care. We reviewed the literatur...

VirA+EmiC project: Evaluating real-world effectiveness and sustainability of integrated...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322278
Journal of Viral Hepatitis; Nebbia G, Ruf M et. al.

Apr 1st, 2022 - Innovative testing approaches and care pathways are required to meet global hepatitis B virus (HBV) and hepatitis C virus (HCV) elimination goals. Routine blood-borne virus (BBV) testing in emergency departments (EDs) in high-prevalence areas is s...

see more →

Guidelines  1 results

Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidan...
https://doi.org/10.1016/j.jhep.2016.08.002
Journal of Hepatology; Easterbrook PJ,

Sep 20th, 2016 - Testing and diagnosis of hepatitis C virus (HCV) infection is the gateway for access to both treatment and prevention services, and crucial for an effective hepatitis epidemic response. In contrast to HIV, a systematic approach to hepatitis C test...

see more →

Clinicaltrials.gov  3 results

A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients
https://clinicaltrials.gov/ct2/show/NCT03284242

Jan 17th, 2023 - The purpose of this research study is to learn alternative ways to control the body's immune responses after renal transplantation. The investigator's goal is to prevent or reduce the side-effects of long-term immunosuppressive therapy. By doing t...

Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
https://clinicaltrials.gov/ct2/show/NCT01243190

Feb 25th, 2022 - The Study Drug: Ofatumumab is designed to bind to the surface of some of the white blood cells (B-cells). It may destroy cancer cells that come from B-cells. Study Drug Administration: If you are found to be eligible to take part in this study, yo...

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
https://clinicaltrials.gov/ct2/show/NCT02060162

Nov 12th, 2021 - The study will take place during routinely scheduled ART visits as per Ministry of Health guidelines. Routinely collected programmatic data will be used to assess general HIV outcomes (CD4 response, loss to follow-up, death) as well as collecting ...

see more →

News  16 results

Awareness Critical for Identifying irAEs Early in Breast Cancer
https://www.onclive.com/view/awareness-critical-for-identifying-iraes-early-in-breast-cancer

Dec 20th, 2020 - Hope Rugo, MD With tremendous advances and the accelerated approval of atezolizumab (Tecentriq) plus nab-paclitaxel (Abraxane) for patients with unresectable locally advanced or metastatic PD-L1—positive triple-negative breast cancer, provider ed...

Hepatitis Awareness Month and Testing Day - May 2019
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/397705

May is Hepatitis Awareness Month, and May 19 is Hepatitis Testing Day. Many people with hepatitis B and hepatitis C remain unaware of their infection until serious complications occur.

New Ebola Species; 100 Years of Flu; Grocery Store Parasites
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/74354

Aug 1st, 2018 - The government of Sierra Leone announced the discovery of a new species of Ebola virus in bats, and researchers think it could infect human cells. (STAT) Ahead of its October 23 PDUFA date, 96-week data from doravirine (Merck), a non-nucleotide re...

Hepatitis Awareness Month and Testing Day, May 2018
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/380542

The United States commemorates National Hepatitis Awareness Month each May, and May 19 is designated as Hepatitis Testing Day. Viral hepatitis still persists as a major public health threat despite availability of preventive measures such as vacci...

Apps and Social Media Can Reach High-Risk HIV Populations
https://www.staging.medscape.com/viewarticle/871137

Oct 28th, 2016 - GLASGOW, United Kingdom — Mobile applications and social media platforms can be cheap and effective ways to deliver messages about HIV testing and adherence to therapy to people at high risk for HIV, experts said here at HIV Drug Therapy 2016. One...

see more →

Patient Education  1 results see all →